Drug Trial Radar · NCT00151762
Long-Term Study of Safety and Efficacy of WelChol® as an Additional Therapy in Patients With Type 2 Diabetes
Last checked: Nov 19, 2026Latest source record: Jan 9, 2008 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
780
Actual
Start
Dec 2004
Primary completion
Jul 2007
Study completion Jul 2007
Sponsor
- Lead sponsor
- Daiichi SankyoDaiichi Sankyo (DSNKY)
- Sponsor type
- Industry
- First posted
- Sep 9, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Non randomized
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This extension study is designed to evaluate the long-term safety and tolerability of colesevelam hydrochloride (WelChol®) in patients with type 2 diabetes.
Conditions
- Type 2 Diabetes
Interventions
Colesevelam hydrochlorideDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- To evaluate safety and tolerability of colesevelam hydrochloride as add-on therapy
Locations
64 sites in 3 countries. Site status is shown where the registry gives one.
Site not named
Birmingham, Alabama
Site not named
Tuscumbia, Alabama
Site not named
Jonesboro, Arkansas
Site not named
Little Rock, Arkansas
Site not named
Searcy, Arkansas
Site not named
Carmichael, California
Site not named
Concord, California
Site not named
Irvine, California
Site not named
La Jolla, California
Site not named
Los Angeles, California
Site not named
Los Gatos, California
Site not named
San Diego, California
Site not named
Spring Valley, California
Site not named
West Hills, California
Site not named
Washington D.C., District of Columbia
Site not named
Cocoa Beach, Florida
Site not named
Coral Gables, Florida
Site not named
Largo, Florida
Site not named
Miami, Florida
Site not named
New Port Richey, Florida
Site not named
Pembroke Pines, Florida
Site not named
West Palm Beach, Florida
Site not named
Atlanta, Georgia
Site not named
Chicago, Illinois
Site not named
Evansville, Indiana
Site not named
Indianapolis, Indiana
Site not named
Lexington, Kentucky
Site not named
Louisville, Kentucky
Site not named
New Orleans, Louisiana
Site not named
Boston, Massachusetts
Site not named
Detroit, Michigan
Site not named
Troy, Michigan
Site not named
Edina, Minnesota
Site not named
Kansas City, Missouri
Site not named
St Louis, Missouri
Site not named
Bozeman, Montana
Site not named
Butte, Montana
Site not named
Las Vegas, Nevada
Site not named
Rochester, New York
Site not named
Charlotte, North Carolina
Showing 40 of 64 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.